drugset / Trial / NCT02432677

Evaluation of the Potentiating Effect of tDCS on Opioid Analgesia of Pain Threshold in Humans

NCT02432677

Phase 2 Unknown 48 enrolled Hospital de Clinicas de Porto Alegre
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the potential additive effect of tDCS compared to placebo-sham in opioid analgesia on pain thresholds in nociceptive experimental model in healthy volunteers .

Timeline

Start
2014-07
Primary completion
2015-12
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 0.06 ug/kg Intravenous

Indications

No indication recorded.